(Q34360517)

1 August 2017

1 reference

title

Managing the highly sensitized transplant recipient and B cell tolerance (English)

1 reference

1 August 2017

Baid S

1

1 reference

1 August 2017

Saidman SL

2

1 reference

1 August 2017

Tolkoff-Rubin N

3

1 reference

1 August 2017

Williams WW

4

1 reference

1 August 2017

Delmonico FL

5

1 reference

1 August 2017

Cosimi AB

6

1 reference

1 August 2017

Pascual M

7

1 reference

1 August 2017

1 October 2001

1 reference

Current Opinion in Immunology

1 August 2017

1 reference

1 August 2017

13

1 reference

1 August 2017

577-581

1 reference

1 August 2017

5

1 reference

Laboratory and clinical management of the highly sensitized organ transplant recipient

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Cardiac and lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Cross-matching in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

The lymphocytotoxic crossmatch test in clinical renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Sensitization and sensitivity: defining the unsensitized patient

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

"Hyperacute" renal-homograft rejection in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Significance of the positive crossmatch test in kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Kidney Transplantation in Modified Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Humoral Antibodies in Renal Allotransplantation in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

The renal allograft biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Chronic rejection and chronic cyclosporin toxicity in renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Postoperative production of anti-donor antibody and chronic rejection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Why do we reject a graft? Role of indirect allorecognition in graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Renal transplantation after removal of anti-HLA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Immunosuppressive strategies in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Rapamycin in transplantation: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Tolerance to vascularized organ allografts in large-animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Mixed chimerism and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

The abrogation of allosensitization following the induction of mixed allogeneic chimerism.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900262-4

7 January 2021

10.1016/S0952-7915(00)00262-4

Identifiers

DOI

1 reference

1 August 2017

1 reference